Corporate Governance
Good governance is an important factor in the effective management of Angiotech's operations. Shareholders expect, and are entitled to, a Board that capably represents their interests in overseeing management. The Company's Board of Directors currently consists of six independent members and one executive member. The role of Chair is assumed by an independent director and is separate from the role of Chief Executive Officer. Independent directors also chair the three committees of the Board. Each director brings unique experiences and skills in providing oversight and governance. All committees consist of independent directors.
Angiotech's Board of Directors
Click on the director's name to read a corresponding biography.
- David T. Howard, Chairman of the Board
- William L. Hunter, President & CEO
- Hank McKinnell
- Hartley T. Richardson
- Ned Brown
- Arthur H. Willms
- Laura A. Brege
Codes of Ethics
- Guide of Standards and Business Conduct
- Code of Ethics for Chief Executive Officer
- Code of Ethics for Chief Financial Officer
- Code of Ethics for Directors and Officers
Committee Charters
- Charter of Board Governance and Expectations
- Governance and Nominating Committee Charter
- Compensation Committee Charter
- Audit Committee Charter
Read more about Angiotech's Management Team